Skiplink Navigation

Main Features

Cheaper prices slow down pharma market growth

The Swiss pharmaceutical market increased in value by 3.4 per cent last year, reaching almost SFr4.9 billion ($4.71 billion), but growth is slowing down.

Cheaper prices, both for patented medicines and generics, were cited as the reason for the slowdown from the 5.5 per cent increase recorded in 2008.

The savings totalled more than SFr400 million, according to an analysis by IMS Health.

It said that the use of generics in hospitals had increased significantly, up 3.9 per cent to SFr449 million compared with the previous year.

IMS Health added that the pharmaceutical market could contract by between one and three per cent this year. and agencies


Neuer Inhalt

Horizontal Line

subscription form

Form for signing up for free newsletter.

Sign up for our free newsletters and get the top stories delivered to your inbox.

Click here to see more newsletters

swissinfo EN

The following content is sourced from external partners. We cannot guarantee that it is suitable for the visually or hearing impaired.

Join us on Facebook!